Kymera Therapeutics (KYMR) Q4 2022 Earnings

23FebConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.79
-0.73
-0.66
-0.6

Details

Expected EPS
-0.63
Actual EPS
-0.6
Surprise EPS
0.03
Surprise Percent
+4.76%

Description

Kymera Therapeutics (KYMR) has reported earnings of -0.6 per share for Q4 2022.

0 Comments

Share your thoughts